Nathan Bryson

Chief Scientific Officer @Reunion Neuroscience

Toronto, ON, CA
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2022 — Present

Chief Scientific Officer @Reunion Neuroscience

View department →

Toronto, ON, CA

Reunion Neuroscience is an early stage pharmaceutical company developing new molecules to treat mental health conditions. Our team is composed of successful entrepreneurs and scientific leaders with deep experience in nearly every aspect of pharmaceutical development. We’re pursuing next generation therapeutics to heal people with unmet mental health needs. Previously a part of Field Trip Health Ltd, Reunion is now an independent public company focused on developing therapeutics. The board unanimously approved the reorganization in April of 2022, with Field Trip Health now being renamed Reunion Neuroscience Inc.

EDUCATION

1988 — 1988

University of Strasbourg

NATO Post-doctoral Fellow, Organometallic synthesis

1981 — 1984

Auburn University

BSc, Chemistry

1984 — 1988

Massachusetts Institute of Technology

PhD, Chemistry, Radiopharmaceuticals

1989 — 1990

Massachusetts Institute of Technology

Post-doctorate, Polymers

SKILLS

ChemistryPatentsProject ManagementAnalyticsDrug DeliveryLife SciencesClinical ResearchIntellectual PropertyStrategyBiotechnologyStart-UpsProduct DevelopmentTechnology TransferFormulationR&DLifesciencesDrug DevelopmentClinical Development

ABOUT NATHAN BRYSON

Chief Scientific Officer at Reunion Neuroscience

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Nathan Bryson — Chief Scientific Officer at Reunion Neuroscience in Toronto, ON, CA | Unifers